- Filed
- Nov 13, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · Nov 13, 2025 | 9.08M sh |
| Operating Cash Flow | Q3 2025 · Sep 30, 2025 | −$880.09K |
| Operating Cash Flow | Q3 2025 · Sep 30, 2024 | $0 |
| Cash And Equivalents | Q3 2025 · Sep 30, 2025 | $66.63K |
| Cash And Equivalents | Q3 2025 · Dec 31, 2024 | $646.72K |
| Cash And Equivalents | Q3 2025 · Sep 30, 2024 | $0 |
| Cash And Equivalents | Q3 2025 · Dec 31, 2023 | $0 |
| Stockholders Equity | Q3 2025 · Sep 30, 2025 | −$436.29K |
| Stockholders Equity | Q3 2025 · Jun 30, 2025 | −$311.77K |
| Stockholders Equity | Q3 2025 · Mar 31, 2025 | $197.4K |
| Stockholders Equity | Q3 2025 · Dec 31, 2024 | $450.88K |
| Stockholders Equity | Q3 2025 · Sep 30, 2024 | −$23.97K |
| Stockholders Equity restated | Q3 2025 · Jun 30, 2024 | −$9.64K |
| Stockholders Equity | Q3 2025 · Mar 31, 2024 | −$7.36K |
| Stockholders Equity | Q3 2025 · Dec 31, 2023 | −$4.26K |
| Current Liabilities | Q3 2025 · Sep 30, 2025 | $558.75K |
| Current Liabilities | Q3 2025 · Dec 31, 2024 | $269.34K |
| Total Liabilities | Q3 2025 · Sep 30, 2025 | $558.75K |
| Total Liabilities | Q3 2025 · Dec 31, 2024 | $269.34K |
| Current Assets | Q3 2025 · Sep 30, 2025 | $122.46K |
| Current Assets | Q3 2025 · Dec 31, 2024 | $720.21K |
| Total Assets | Q3 2025 · Sep 30, 2025 | $71.66M |
| Total Assets | Q3 2025 · Dec 31, 2024 | $70.06M |
| Eps Diluted | Q3 2025 · Sep 30, 2025 | $0.09 |
| Eps Diluted | Q3 2025 · Sep 30, 2025 | $0.22 |
| Eps Diluted restated | Q3 2025 · Sep 30, 2024 | $0.00 |
| Eps Diluted restated | Q3 2025 · Sep 30, 2024 | $0.00 |
| Net Income | Q3 2025 · Sep 30, 2025 | $615.03K |
| Net Income | Q3 2025 · Sep 30, 2025 | $1.31M |
| Net Income | Q3 2025 · Sep 30, 2024 | −$33.6K |
| Net Income | Q3 2025 · Sep 30, 2024 | −$44.71K |